Deep Track Capital's book
16 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Tubulis | Drug Discovery | $5.8B | — | — | |
| Halda Therapeutics | Drug Discovery | $3.0B | — | — | |
| 35Pharma | — | $950.0M | — | — | |
| Avenzo Therapeutics | — | $590.0M | — | — | |
| Latigo Bio | — | $530.0M | — | — | |
| Diagonal Therapeutics | Drug Discovery | $458.5M | — | — | |
| Hemab Therapeutics Holdings | Drug Discovery | $386.9M | — | — | |
| Attovia Therapeutics | — | $370.0M | — | — | |
| Triveni Bio | Drug Discovery | $310.0M | — | — | |
| Artios | Drug Discovery | $260.3M | — | — | |
| + 6 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 16 recorded positions
- ·Watchlist + alerts for Deep Track Capital's activity
Create free account
No card required